Dietary fructose intake in obese children and adolescents: Relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease

Journal of Pediatric Endocrinology and Metabolism

Volumn 29, Issue 12, 2016, Pages 1345-1352

  Hamza, Rasha Tarif ^a   Ahmed, Alaa Youssef ^a   Rezk, Doaa Gamal ^a   Hamed, Amira Ibrahim ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

dietary; fructose; nonalcoholic fatty liver disease; obesity; procollagen type III N terminal peptide

Indexed keywords

ALANINE AMINOTRANSFERASE; FRUCTOSE; GLUCOSE; INSULIN; LIPID; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; URIC ACID; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE III-N-TERMINAL PEPTIDE; SWEETENING AGENT;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CASE CONTROL STUDY; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FRUCTOSE INTAKE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRESCHOOL CHILD; REFERENCE VALUE; SCHOOL CHILD; SEXUAL MATURITY; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADVERSE EFFECTS; ANTHROPOMETRY; BLOOD; COMPARATIVE STUDY; COMPLICATION; DIET; INSULIN RESISTANCE; NON-ALCOHOLIC FATTY LIVER DISEASE; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ANTHROPOMETRY; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; DIET; ENERGY INTAKE; FEMALE; FRUCTOSE; HUMANS; INSULIN RESISTANCE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROGNOSIS; RISK FACTORS; SWEETENING AGENTS;

EID: 85002253452     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2016-0015     Document Type: Article

References (39)

1. Marzuillo P, Grandone A, Perrone L, Miraglia Del Giudice E. Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease. World J Gastroenterol 2015;21:6444-50.
2. Papandreou D, Andreou E. Role of diet on non-alcoholic fatty liver disease: an updated narrative review. World J Hepatol 2015;7:575-82.
3. Tanwar S, Trembling PM, Guha IN, Parkes J, Kaye P, et al. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitisin patients with nonalcoholic fatty liver disease. Hepatology 2013;57: 103-11.
4. Niemelä O, Risteli L, Parkkinen J, Risteli J. Purification and characterization of the N-terminal propeptide of human type III procollagen. Biochem 1985;232:145-50.
5. Bolarin DM, Azinge EC. Biochemical markers, extracellular components in liver fibrosis and cirrhosis. Nig Q J Hosp Med 2007;17:42-52.
6. Cole TJ. A chart to link child centiles of body mass index, weight and height. Eur J Clin Nutr 2002;56:1196-9.
7. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity; British children, 1965. Arch Dis Child 1966;41:454-71, 613-35.
8. Schwandt P, Kelishadi R, Haas G. First reference curves of waist circumference for German children in comparison to international values: the PEP Family Heart Study. World J Pedi-atr 2008;4:259-66.
9. Mederico M, Paoli M, Zerpa Y, Briceño Y, Gómez-Pérez R, et al. Reference values of waist circumference and waist/hip ratio in children and adolescents of Mérida, Venezuela: comparison with international references. Endocrinol Nutr 2013;60:235-42.
10. Moreno LA, Fleta J, Mur L, Rodríquez G, Sarría A, et al. Waist circumference values in Spanish children-gender related differences. Eur J Clin Nutr 1999;53:429-33.
11. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
12. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
13. National High Blood Pressure Education Program. Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996;98:649-58.
14. Dwyer JL. Dietary assessment in modern nutrition in health and disease, 12th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2003.
15. Food Frequency Questionnaire: University of Cambridge. EPIC-Norfolk: nutritional methods. Available at: http://www.srl.cam. ac.uk/epic/nutmethod/FFQ.shtml. Accessed on 2/4/2013.
16. Mahmoud KA, Armanious NN, Youssef SS, Abdullah RM, Said FS, et al. Dietary fructose. In: Hassan HA, Mosea W, Khadr S, editors. Health food guide for the Egyptian family, 4th edn. Cairo: National Institute of Nutrition, 2005.
17. National Nutrition Institute. Food composition tables for Egypt, 2nd ed. Cairo, ARE: National Nutrition Institute, 2006.
18. Soldin SJ. Uric acid, serum. In: Soldin SJ, Brugnara C, Wong EC, editors. Pediatric reference intervals, 6th edn. Washington, DC: AACC Press, 2007:270.
19. National Cholesterol Education Program (NCEP). Expert panel of blood cholesterol levels in children and adolescents. Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:495-501.
20. American Diabetes Association Standards of Care for Diabetes. Brief summary of screening and diagnosis of type 2 diabetes and its complications. Diabetes Care 2013;36:S1.
21. Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistery, 2nd ed. Philadelphia: W.B. Saunders Co, 1994.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
23. Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006;16:279-84.
24. Tester J, Sharma S, Jasik CB, Mietus-Snyder M, Tinajero-Deck L. Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California. Diabetes Metab Syndr 2013;7:161-5.
25. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:3.
26. Singh AK, Amlal H, Haas PJ, Dringenberg U, Fussell S, et al. Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5. Kidney Int 2008;74:438-47.
27. Jia G, Aroor AR, Whaley-Connell AT, Sowers JR. Fructose and uric acid: is there a role in endothelial function? Curr Hypertens Rep 2014;16:434.
28. Miller A, Adeli K. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 2008;24:204-9.
29. Schaefer EJ, Gleason JA, Dansinger ML. Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J Nutr 2009;139:1257S-62S.
30. Friedland O, Nemet D, Gorodnitsky G, Wolach B, Eliakim A. Obesity and lipid profiles in children and adolescents. J Pediat Endocr Met 2002;15:1011-6.
31. Kelishadi R, Mirmoghtadaee P, Najafi H, Keikha M. Systematic review on the association of abdominal obesity in children and adolescents with cardio-metabolic risk factors. J Res Med Sci 2015;20:294-307.
32. Aeberli I, Zimmermann MB, Molinari L, Lehmann R, l'Allemand D, et al. Fructose intake is a predictor of LDL particle size in overweight school children. Am J Clin Nutr 2007;86:1174-8.
33. Chung M, Ma J, Patel K, Berger S, Lau J, et al. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: asystematic review and meta-analysis. Am J Clin Nutr 2014;100:833-49.
34. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. Br Med J 2008;336:309-12.
35. Nguyen S, Choi HK, Lustig RH, Hsu CY. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr 2009;154:807-13.
36. Welsh JA, Sharma A, Cunningham SA, Vos MB. Consumption of added sugars and indicators of cardiovascular disease risk among US adolescents. Circulation 2011;123:249-57.
37. Arslan N, Tokgoz Y, Kume T, Bulbul M, Sayin O, et al. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents. J Pediatr Endocr Met 2013;26:1141-7.
38. Sullivan JS, Le MT, Pan Z, Rivard C, Love-Osborne K, et al. Oral fructose absorption in obese children with non-alcoholic fatty liver disease. Pediatr Obes 2015;10:188-95.
39. Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010;90:23-46.